4NIGHTINGALE C H,MURAKAWA T,AMBROSE P G,et al.Anti-microbial pharmacodynamics in theory and clinical practice[M].New York:Marcel Dek ker,InC,2002:385-408.
5ZHANEL G G.Influence of pharmacokinetic and pharmacodynamic principles on antibiotic selection[J].Curr Infect Dis Rep,2004,3(1):29-34.
6ODENHOLD-TORNGVIST I,HOHN S E.Pharmacodynamic effects of subinhibitory antibiotic concentrations[J].Scan J Infect Dis,1997,74(1):94.
7VOGELNAN B,CRAIG W A.Postantibiotic effects[J].J Anti Chem,1985,15(1):37.
8HYATT J M,MCKINNON P S,ZIMMER G S,et al.The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome[J].Clin Pharmacoki,1995,28(2):143-160.
10Wilkinson T M,Donaldson G C, Hurst J R, et al. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med,2004,169 (12) : 1298-1303.
